News resources

Today's most mentioned stocks
Wal-Mart Stores Inc (WMT)44 stories...
Google Inc (GOOG)42 stories...
Citigroup Inc (C)38 stories...
Bank of America Corp (BAC)36 stories...
Amazon.com Inc (AMZN)35 stories...
Topics in the news
Movers
Earnings Reports
OTC/Small Caps
Personnel Announcements
Mergers and Acquisitions
advertisement

Incyte Corp: All Recent News

10 Stocks Shaking the Market 8:58 AM
These stocks have been looking up over the past month. At Motley Fool
Incyte 3Q loss narrows on lower costs 11/5/2009
WILMINGTON, Del. (AP) - Biotechnology company Incyte Corp. said Thursday its third-quarter loss narrowed on lower costs as it prioritized is pipeline of potential products. Associated Press
Incyte Reports Third Quarter 2009 Financial Results and... 11/5/2009
Incyte Corporation (Nasdaq:INCY) today reported third quarter 2009 financial results and provided an update on its lead programs. Paul A. Friedman, M.D., Incyte's President and Chief Executive... Business Wire
Trading Outlook for Incyte Corp. Issued by StockPreacher.com 10/28/2009
DALLAS, Oct. 28, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring biopharmaceutical company Incyte Corp. (Nasdaq:INCY). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision. GlobeNewswire
Incyte to Report Third Quarter 2009 Financial Results and... 10/20/2009
Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its third quarter 2009 financial results conference call for 8:30 a.m. ET on Thursday, November 5, 2009. The schedules for the... Business Wire
Incyte to Present at the Fourth Annual JMP Securities... 9/30/2009
Incyte Corporation (Nasdaq:INCY) announced today it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Monday, October 5, 2009 at 10:30 a.m. ET. Presenting for Incyte... Business Wire
Incyte Completes Offering of Convertible Senior Notes 9/30/2009
Incyte Corporation (Nasdaq:INCY) today announced that it has completed its previously announced private placement of $400.0 million aggregate principal amount of 4.75% Convertible Senior Notes due... Business Wire
Incyte Announces Closing of Public Offering of Common Stock 9/30/2009
Incyte Corporation (Nasdaq:INCY) today announced the closing of its public offering of 20,700,000 shares of its common stock at a price to the public of $6.75 per share, which includes 2,700,000... Business Wire
Incyte Prices $350 Million Convertible Senior Notes Offering 9/24/2009
Incyte Corporation (Nasdaq: INCY) today announced the pricing of its offering of $350 million aggregate principal amount of 4.75% Convertible Senior Notes due 2015 in a private placement to... Business Wire
Incyte Announces Pricing of Public Offering of 18,000,000... 9/24/2009
Incyte Corporation (Nasdaq:INCY) today announced the pricing of its underwritten public offering of 18,000,000 shares of its common stock at a price to the public of $6.75 per share. The offering is... Business Wire
Incyte Announces Proposed Offering of $250 Million Convertible... 9/22/2009
Incyte Corporation (Nasdaq:INCY) today announced that it intends to offer, subject to market and other conditions, up to $250 million aggregate principal amount of Convertible Senior Notes due 2015... Business Wire
Incyte Announces Proposed Public Offering of 18,000,000 Shares... 9/22/2009
Incyte Corporation (Nasdaq:INCY) today announced that it intends to offer to sell, subject to market and other conditions, 18,000,000 shares of its common stock in an underwritten public offering. Business Wire
Market Report -- Story Stocks (INCY) 9/21/2009
Incyte Incyte (INCY 7.95, +0.66) announced positive top-line Phase IIb results this morning for Topical INCB18424 in Psoriasis. The company said these results were obtained from a... Briefing.com
Incyte Announces Positive Top-Line Phase IIb Results for... 9/21/2009
Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis. These results were obtained... Business Wire
Incyte to Present at Upcoming Investor Conferences 9/3/2009
Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences: Baird 2009 Health Care Conference on Wednesday, September 9, 2009 at 10:00 a.m. (ET) in New... Business Wire

More News
Market Report
News by Symbol
Today's Investing Articles
Breaking News
News by Topic
News by Industry
MSNBC News
MSN Money
Search MSN Money
Message Boards
Site Status